articleTop 1% cited
Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Nature Medicine · 2007 · Vol. 13(9) · pp. 1050–1059
Lionel Apétoh✉(Institut Gustave Roussy)François Ghiringhelli(Institut Gustave Roussy)Antoine Tesnière(Institut Gustave Roussy)Michel Obéid(Institut Gustave Roussy)Carla Ortiz(Institut Gustave Roussy)Alfredo Criollo(Institut Gustave Roussy)Grégoire Mignot(Institut Gustave Roussy)Maria Chiara Maiuri(Institut Gustave Roussy)Evelyn Ullrich(Université Paris-Sud)Patrick Saulnier(Laboratoire d'études sur les monothéismes)Huan Yang(Feinstein Institute for Medical Research)Sebastián Amigorena(Inserm)Bernard Ryffel(Centre National de la Recherche Scientifique)Franck J. Barrat(Dynavax Technologies (United States))Paul Säftig(Christian-Albrechts-Universität zu Kiel)Françis Lévi(Université Paris-Sud)Rosette Lidereau(Inserm)Catherine Noguès(Inserm)Jean‐Paul Mira(Centre National de la Recherche Scientifique)Agnès Chompret(Laboratoire d'études sur les monothéismes)V. Joulin(Centre National de la Recherche Scientifique)Françoise Clavel‐Chapelon(Inserm)Jean Bourhis(Laboratoire d'études sur les monothéismes)Fabrice André(Laboratoire d'études sur les monothéismes)Suzette Delaloge(Laboratoire d'études sur les monothéismes)Thomas Tursz(Inserm)Guido Kroemer(Inserm)Laurence Zitvogel(Inserm)
Immune Response and InflammationImmunotherapy and Immune ResponsesImmune Cell Function and InteractionImmunogenic cell deathImmunoadjuvantRadiation therapyImmune systemCancer researchToll-like receptorHMGB1Acquired immune systemTLR4Immunotherapy
MeSH terms
AnimalsAntineoplastic AgentsBone NeoplasmsColonic NeoplasmsDisease Models, AnimalHumansMice, Inbred BALB CNeoplasmsOrganoplatinum CompoundsPyridinesOsteosarcomaCell Line, TumorToll-Like Receptor 4Mice
Citations
2,933
FWCI
40.35
field-weighted impact
References
49
Percentile
100%
vs. same field & year
Citations per year
Cited by
Immunogenic Cell Death in Cancer Therapy
Annual Review of Immunology · 2012 · 3,154 citations
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
Oncotarget · 2013 · 390 citations
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
Annual Review of Immunology · 2011 · 1,391 citations
Natural Innate and Adaptive Immunity to Cancer
Annual Review of Immunology · 2011 · 2,024 citations
Endogenous ligands of TLR2 and TLR4: agonists or assistants?
Journal of Leukocyte Biology · 2010 · 511 citations
Pattern Recognition Receptors and the Host Cell Death Molecular Machinery
Frontiers in Immunology · 2018 · 719 citations
Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
Clinical Cancer Research · 2011 · 893 citations
The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance
Immunological Reviews · 2008 · 636 citations
References
Cutting Edge: Toll-Like Receptor 4 (TLR4)-Deficient Mice Are Hyporesponsive to Lipopolysaccharide: Evidence for TLR4 as the <i>Lps</i> Gene Product
The Journal of Immunology · 1999 · 3,357 citations
Toll-like receptors and innate immunity
Nature reviews. Immunology · 2001 · 4,244 citations
Calreticulin exposure dictates the immunogenicity of cancer cell death
Nature Medicine · 2006 · 3,040 citations
In Vivo Depletion of CD11c+ Dendritic Cells Abrogates Priming of CD8+ T Cells by Exogenous Cell-Associated Antigens
Immunity · 2002 · 1,725 citations
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
Journal of Immunological Methods · 1999 · 2,961 citations
High mobility group box 1 protein interacts with multiple Toll-like receptors
American Journal of Physiology-Cell Physiology · 2005 · 933 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
